163 related articles for article (PubMed ID: 31805980)
1. Could aspirin be a lifesaver for prostate cancer patients in prostate cancer-specific mortality?: an update systematic review and meta-analysis.
Zhou J; Xia S; Li T; Liu R
BMC Cancer; 2019 Dec; 19(1):1186. PubMed ID: 31805980
[TBL] [Abstract][Full Text] [Related]
2. The impact of surgical margin status on prostate cancer-specific mortality after radical prostatectomy: a systematic review and meta-analysis.
Zhang B; Zhou J; Wu S; Guo M; Zhang Y; Liu R
Clin Transl Oncol; 2020 Nov; 22(11):2087-2096. PubMed ID: 32410119
[TBL] [Abstract][Full Text] [Related]
3. Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians' Health Study.
Downer MK; Allard CB; Preston MA; Gaziano JM; Stampfer MJ; Mucci LA; Batista JL
Eur Urol; 2017 Nov; 72(5):821-827. PubMed ID: 28189429
[TBL] [Abstract][Full Text] [Related]
4. Advancing age within established Gleason score categories and the risk of prostate cancer-specific mortality (PCSM).
Russo AL; Chen MH; Aizer AA; Hattangadi JA; D'Amico AV
BJU Int; 2012 Oct; 110(7):973-9. PubMed ID: 22954029
[TBL] [Abstract][Full Text] [Related]
5. Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study.
Gnanapragasam VJ; Lophatananon A; Wright KA; Muir KR; Gavin A; Greenberg DC
PLoS Med; 2016 Aug; 13(8):e1002063. PubMed ID: 27483464
[TBL] [Abstract][Full Text] [Related]
6. Aspirin Exposure and Mortality Risk among Prostate Cancer Patients: A Systematic Review and Meta-Analysis.
Fan LL; Xie CP; Wu YM; Gu XJ; Chen YH; Wang YJ
Biomed Res Int; 2019; 2019():9379602. PubMed ID: 31073532
[TBL] [Abstract][Full Text] [Related]
7. Short-term androgen-deprivation therapy improves prostate cancer-specific mortality in intermediate-risk prostate cancer patients undergoing dose-escalated external beam radiation therapy.
Zumsteg ZS; Spratt DE; Pei X; Yamada Y; Kalikstein A; Kuk D; Zhang Z; Zelefsky MJ
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1012-7. PubMed ID: 22981709
[TBL] [Abstract][Full Text] [Related]
8. Risk Group and Death From Prostate Cancer: Implications for Active Surveillance in Men With Favorable Intermediate-Risk Prostate Cancer.
Raldow AC; Zhang D; Chen MH; Braccioforte MH; Moran BJ; D'Amico AV
JAMA Oncol; 2015 Jun; 1(3):334-40. PubMed ID: 26181182
[TBL] [Abstract][Full Text] [Related]
9. Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up Study.
Downer MK; Allard CB; Preston MA; Wilson KM; Kenfield SA; Chan JM; Mucci LA; Giovannucci E; Stampfer MJ
Eur Urol Oncol; 2019 Mar; 2(2):126-134. PubMed ID: 31017087
[TBL] [Abstract][Full Text] [Related]
10. The impact of PSA and digital rectal examination on the risk of prostate cancer specific mortality in men with a PSA level <2.5 ng/ml.
Pashtan I; Chen MH; D'Amico AV
Cancer Epidemiol; 2014 Oct; 38(5):613-8. PubMed ID: 25164550
[TBL] [Abstract][Full Text] [Related]
11. Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy.
Zhou P; Chen MH; McLeod D; Carroll PR; Moul JW; D'Amico AV
J Clin Oncol; 2005 Oct; 23(28):6992-8. PubMed ID: 16192586
[TBL] [Abstract][Full Text] [Related]
12. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer.
Ham WS; Chalfin HJ; Feng Z; Trock BJ; Epstein JI; Cheung C; Humphreys E; Partin AW; Han M
Eur Urol; 2017 Jun; 71(6):907-912. PubMed ID: 27876305
[TBL] [Abstract][Full Text] [Related]
13. Daily aspirin use and prostate cancer-specific mortality in a large cohort of men with nonmetastatic prostate cancer.
Jacobs EJ; Newton CC; Stevens VL; Campbell PT; Freedland SJ; Gapstur SM
J Clin Oncol; 2014 Nov; 32(33):3716-22. PubMed ID: 25332245
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer-specific mortality after radical prostatectomy: value of preoperative MRI.
Woo S; Cho JY; Ku JH; Kim SY; Kim SH
Acta Radiol; 2016 Aug; 57(8):1006-13. PubMed ID: 26508791
[TBL] [Abstract][Full Text] [Related]
15. Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate cancer after salvage radiation for prostate cancer.
Johnson SB; Hamstra DA; Jackson WC; Zhou J; Foster B; Foster C; Song Y; Li D; Palapattu GS; Kunju L; Mehra R; Sandler H; Feng FY
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):275-81. PubMed ID: 23886418
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy.
Mossanen M; Nepple KG; Grubb RL; Androile GL; Kallogjeri D; Klein EA; Stephenson AJ; Kibel AS
Eur Urol Oncol; 2018 Jun; 1(2):143-148. PubMed ID: 31100238
[TBL] [Abstract][Full Text] [Related]
17. Initial management of prostate-specific antigen-detected, low-risk prostate cancer and the risk of death from prostate cancer.
Aizer AA; Chen MH; Hattangadi J; D'Amico AV
BJU Int; 2014 Jan; 113(1):43-50. PubMed ID: 23473327
[TBL] [Abstract][Full Text] [Related]
18. Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
Vidal AC; Howard LE; Sun SX; Cooperberg MR; Kane CJ; Aronson WJ; Terris MK; Amling CL; Freedland SJ
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):72-78. PubMed ID: 27698439
[TBL] [Abstract][Full Text] [Related]
19. Recreational Physical Activity in Relation to Prostate Cancer-specific Mortality Among Men with Nonmetastatic Prostate Cancer.
Wang Y; Jacobs EJ; Gapstur SM; Maliniak ML; Gansler T; McCullough ML; Stevens VL; Patel AV
Eur Urol; 2017 Dec; 72(6):931-939. PubMed ID: 28711382
[TBL] [Abstract][Full Text] [Related]
20. Ten-year survival after High-Dose-Rate Brachytherapy combined with External Beam Radiation Therapy in high-risk prostate cancer: A comparison with the Norwegian SPCG-7 cohort.
Wedde TB; Småstuen MC; Brabrand S; Fosså SD; Kaasa S; Tafjord G; Russnes KM; Hellebust TP; Lilleby W
Radiother Oncol; 2019 Mar; 132():211-217. PubMed ID: 30389241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]